Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gangadharan

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Indian Pediatrics|August 1, 1977
School health service programme in Kerala--a rural studyM Gangadharan
Japanese Journal of Ophthalmology|January 1, 1986
Bilaterally symmetrical isolated corectopia: a case reportM Gangadharan, G Menon
Molecular Biotherapy|January 1, 1989
Modification of L-asparaginase from Erwinia carotovora using human serum albuminD P Nerkar, M Gangadharan
Obstetric Medicine|August 16, 2021
Postpartum atypical hemolytic uremic syndrome: Evaluating thrombotic microangiopathy in the pregnant womanS So, E Fischer, M Gangadharan Komala, et al.
Blood|July 18, 2025
The interleukin-33 receptor (ST2) is a novel therapeutic target to attenuate the progression of hemophilic arthropathyHeike C Hawerkamp, Aoife Yeow, Ciara Byrne, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Indian Pediatrics|August 1, 1977
School health service programme in Kerala--a rural studyM Gangadharan
Japanese Journal of Ophthalmology|January 1, 1986
Bilaterally symmetrical isolated corectopia: a case reportM Gangadharan, G Menon
Molecular Biotherapy|January 1, 1989
Modification of L-asparaginase from Erwinia carotovora using human serum albuminD P Nerkar, M Gangadharan
Obstetric Medicine|August 16, 2021
Postpartum atypical hemolytic uremic syndrome: Evaluating thrombotic microangiopathy in the pregnant womanS So, E Fischer, M Gangadharan Komala, et al.
Blood|July 18, 2025
The interleukin-33 receptor (ST2) is a novel therapeutic target to attenuate the progression of hemophilic arthropathyHeike C Hawerkamp, Aoife Yeow, Ciara Byrne, et al.
Pageof 1